POLYPEPTIDE GROUP AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.55 CHF | +2.43% |
|
+1.90% | +68.66% |
| 12/03 | PolyPeptide Group AG Provides Earnings Guidance for 2024 | CI |
| 12/03 | Transcript : PolyPeptide Group AG, 2023 Earnings Call, Mar 12, 2024 |
Chart calendar PolyPeptide Group AG
36db561316f6ccbeb9ce0383d198c.3GKS5MGGEZkaaV7_-pH5H5SMVNid3AgR0isn4rYeUbA.hA3EjJDCQ6E3PB23yue0KMznEKDkl210kURhi8ctYfKNM-eDh_d2wzcEZg~8e3513caf90b6f4dcb554ee614a6009e
Upcoming events on PolyPeptide Group AG
Past events on PolyPeptide Group AG
| 10/04/2024 07:30 pm | Annual General Meeting |
| 12/03/2024 03:00 pm | Q4 2023 Earnings Call |
| 12/03/2024 11:15 am | Q4 2023 Earnings Release |
| 29/11/2023 | Nordic Life Science Days |
| 30/10/2023 | TIDES Europe Conference |
| 24/10/2023 | CPHI Conference |
| 16/10/2023 | Peptide Therapeutics Symposium |
| 18/09/2023 | Boulder Peptide Symposium |
| 17/09/2023 | Groupe Français des Peptides et Protéines Meeting |
| 06/09/2023 | RNA Leaders Congress |
| 15/08/2023 01:00 pm | Q2 2023 Earnings Call |
| 15/08/2023 10:30 am | Q2 2023 Earnings Release |
| 13/07/2023 01:00 pm | Q2 2023 Sales and Revenue Call |
| 13/07/2023 10:30 am | Q2 2023 Sales and Revenue Release |
| 24/04/2023 | Swiss Biotech Day |
| 14/04/2023 | American Association for Cancer Research Meeting |
| 12/04/2023 07:30 pm | Annual General Meeting |
| 30/03/2023 | Biologics UK Conference |
| 20/03/2023 | BIO Europe Spring |
| 15/03/2023 | RNA Leaders Europe Congress |
Past dividends on PolyPeptide Group AG
| 28/04/2022 | 0.3 CHF |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 223 | 282 276 2.13% | 281 285 -1.41% | 325 294 10.39% | 349 |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 | 84,8 89,4 -5.11% | 38,7 43,1 -10.32% | -6,00 -5,57 -7.68% | 26,2 |
|
EBIT Million EUR | Released Forecast Spread | 0,00 | 64,2 68,9 -6.8% | 12,6 19,4 -34.87% | -36,5 -36,9 1.05% | -4,97 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | 59,8 66,5 -10% | 7,57 16,3 -53.67% | -58,2 -44,1 -32.22% | -12,6 |
|
Net income Million EUR | Released Forecast Spread | 31,3 | 47,3 54,6 -13.37% | 7,77 13,3 -41.81% | -51,4 -36,6 -40.73% | -12,2 |
|
EPS EUR | Released Forecast Spread | 0,00 | 1,47 1,66 -11.66% | 0,24 0,41 -41.1% | -1,56 -1,05 -48.99% | -0,30 |
| Announcement Date | 15/03/21 | 15/03/22 | 14/03/23 | 12/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 S1 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 135 | 134 138 -3.26% | 147 151 -2.69% | 132 126 4.44% | 191 167 14.37% | 132 | 213 |
|
EBITDA Million EUR | Released Forecast Spread | 39,9 | 26,7 28,1 -4.99% | -19,4 -5,50 -252.49% | 13,4 13,9 -3.74% | 0,70 | 26,8 | |
|
EBIT Million EUR | Released Forecast Spread | 15,5 15,5 -0.08% | -37,3 | -2,00 -2,54 21.1% | -14,9 | 10,7 | ||
|
Net income Million EUR | Released Forecast Spread | 10,2 11,8 -13.16% | -2,48 1,90 -230.53% | -34,3 -44,9 23.68% | -19,8 | 8,70 | ||
|
EPS EUR | Released Forecast Spread | 0,31 0,36 -12.68% | -1,04 -1,36 23.53% | |||||
| Announcement Date | 17/08/21 | 18/08/22 | 14/03/23 | 15/08/23 | 12/03/24 | - | - |
More events
Past sector events for PolyPeptide Group AG
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PPGN Stock
- Calendar PolyPeptide Group AG
